Atlas Trials

The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM)

Clinical trial NCT03242460 · COMPLETED

Trial details

NCT number
NCT03242460
Sponsor
Kosin University Gospel Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Relapsed and/or refractorY Multiple Myeloma
Start date
2015-05-12
Primary completion
2019-04-24
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.